Previous Chapter Chapter 56: European Markets for Orthopedic Biomaterials Next Chapter
Chapter 56: European Markets for Orthopedic Biomaterials
Comprising Austria, France, Germany, Italy, Spain, and the UK, the European orthopedic biomaterial market was valued at over $205 million in 2005. Orthopedic biomaterials covered in this report are hyaluronic acid (HA) injections, bone graft substitutes (BGS) (bone morphogenic proteins [BMPs], demineralized bone matrices, synthetics, and xenografts), autologous chondrocyte implantation (ACI), and platelet concentration systems (PCS).
The HA viscosupplementation market was the largest contributor to the European orthopedic biomaterial market in 2005. Pricing pressures and increased competition will, however, limit HA market growth over the forecast period. In contrast, the BGS market will experience significant growth over the next few years as surgeons become [Page 509]more aware ...